Company: HROW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000925
Chunk: 132

Company: HARROW, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 132
---
 SHEETS

    December 31,  
    December 31, 

    2024  
    2023 

    ASSETS 

    Current assets 

    Cash and cash equivalents 
    $47,247,000  
    $74,085,000 
  
    Investment in Eton Pharmaceuticals 
     -  
     8,681,000 
  
    Accounts receivable, net 
     116,373,000  
     36,261,000 
  
    Inventories 
     10,702,000  
     10,867,000 
  
    Prepaid expenses and other current assets 
     15,329,000  
     9,588,000 
  
    Total current assets 
     189,651,000  
     139,482,000 
  
    Property, plant and equipment, net 
     3,734,000  
     3,521,000 
  
    Capitalized software costs, net 
     1,751,000  
     2,138,000 
  
    Operating lease right-of-use assets, net 
     8,554,000  
     6,785,000 
  
    Intangible assets, net 
     184,949,000  
     159,906,000 
  
    Goodwill 
     332,000  
     332,000 
  
    TOTAL ASSETS 
    $388,971,000  
    $312,164,000 
  
    LIABILITIES AND STOCKHOLDERS’ EQUITY 

    Current liabilities 

    Accounts payable and accrued expenses 
    $41,406,000  
    $24,581,000 
  
    Accrued rebates and copay assistance 
     39,900,000  
     18,432,000 
  
    Accrued payroll and related liabilities 
     9,496,000  
     5,450,000 
  
    Deferred revenue and customer deposits 
     44,000  
     75,000 
  
    Current portion of operating lease obligations 
     497,000  
     806,000 
  
    Total current liabilities 
     91,343,000  
     49,344,000 
  
    Operating lease obligations, net of current portion 
     8,792,000